FDA Inspection 723394 — Sumitomo Pharma America, Inc.

Sumitomo Pharma America, Inc. — FEI 1222021

The FDA completed an inspection of Sumitomo Pharma America, Inc. on Apr 20, 2011 in Marlborough, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 20, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Marlborough, MA (United States)

Citations

IDCFRDescription
107921 CFR 211.22(a)Contract drug products--lack of responsibility
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications